NCT07197164 Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients Status RECRUITING Phase PHASE2
NCT07178730 NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07163481 A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors Status NOT_YET_RECRUITING Phase PHASE1
NCT07160075 HIV Prevention With PrEP Among People on Opioid Replacement Therapy Status RECRUITING Phase PHASE4
NCT07096193 Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus Status RECRUITING Phase PHASE1/PHASE2
NCT07063212 A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) Status RECRUITING Phase PHASE2
NCT07055451 Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07053527 Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Preexposure Prophylaxis for HIV at an HBCU Status ENROLLING_BY_INVITATION Phase NA
NCT07047716 Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) Status RECRUITING Phase PHASE3
NCT07014618 Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer Status RECRUITING Phase N/A
NCT07004933 Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID) Status COMPLETED Phase N/A
NCT06996938 Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women Status RECRUITING Phase NA
NCT06964113 A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice Status RECRUITING Phase PHASE4
NCT06926920 A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06923826 Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) Status RECRUITING Phase PHASE2
NCT06902519 Study of GS-0151 in Participants With Rheumatoid Arthritis Status RECRUITING Phase PHASE1